MedPath

Predictive Factors of Pelvic Magnetic Resonance in the Response of Arterial Embolization of Uterine Leiomyoma

Completed
Conditions
Exposure to Magnetic Field
Uterine Leiomyoma
Interventions
Procedure: Magnetic Resonance Image
Registration Number
NCT01468402
Lead Sponsor
Hospital Israelita Albert Einstein
Brief Summary

The purpose of this study is to determine predictive factors in the pelvic magnetic resonance in the response of arterial embolization of uterine leiomyoma.

Detailed Description

This study followed symptomatic premenopausal women with uterine leiomyoma who underwent uterine artery embolization (UAE). Treatment was accompanied by magnetic resonance imaging of both the volume of the entire uterus and the leiomyomas one month before and six months after UAE. This patients were treated at the Uterine Leiomyoma Sector of the Department of Obstetrics and Gynecology, Medicine College of the University of São Paulo. In this study, the investigators examined 179 leiomyomas in 50 patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
50
Inclusion Criteria
  • ultrasound diagnosis of uterine leiomyoma
  • presence of symptoms (menorrhalgia and/or pelvic pain)
  • indication for UAE(the desire to keep the uterus and/or contraindications for surgery).
Exclusion Criteria
  • malignant genital neoplasms
  • pelvic inflammatory disease
  • allergy to iodinated contrast
  • coagulopathy, renal failure
  • vasculitis
  • pelvic irradiation
  • pregnancy
  • subserosal leiomyoma with a pedicle smaller than 50% of diameter of the fibroid.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Magnetic Resonanse ImageMagnetic Resonance ImageThe leiomyomas were evaluated individually. MR was used to evaluate morphology: the radiological dimension(s) of the leiomyoma and uterus and the volume. The number of leiomyoma fibroid, and their location in the myometrium was classified. Perfusion and the characterization of the T2 signal were also evaluated.
Primary Outcome Measures
NameTimeMethod
Leiomyoma reduction in patients who underwent uterine artery embolizationOne month before(baseline) and six month after the embolization

Use the magnetic resonanse to evaluate factors that predicted leiomyoma reduction in patients who underwent uterine artery embolization

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital Israelita Albert Einstein

🇧🇷

São Paulo, SP, Brazil

© Copyright 2025. All Rights Reserved by MedPath